Contributing Member of the Healthcare Councils

Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.

GLG News by this Author

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

pump review

June 23, 2008

Analysis of:ArthroCare Sets New Standard In Modern Arthroscopy - Launches New Quantum™ Pump Arthroscopy System In Europe | www.medicalnewstoday.com

Improved pump should be new standard for use in arthroscopic procedures. The proported features of this pump should be very useful for better visualization, ease of use and integrated approach.

Better alternative for short term pain management

May 12, 2008

Analysis of:Johnson & Johnson Presents Tapentadol Phase 3 Clinical Data at American Pain Society's Annual Meeting | www.investor.jnj.com

This artist is important as it introduces an agent for the treatment of acute, moderate to severe pain that initially appears very well tolerated with limited interactions. Recent studies appear to conclude that the gastrointestinal tolerability and drug interactions are very limited in comparison to similar agents. Also, the new mechanism of action appears more effective.

New Tool Pain Managemet

May 12, 2008

Analysis of:New Abbott Study of Investigational Vicodin CR(TM) Meets Primary Efficacy Endpoints in Phase III Trial | www.prnewswire.com

This new study suggests that a new tool will soon be available for use in the management of moderate chronic pain. Vicoden is a well established, widely used and tolerated short acting agent. An FDA approved long acting version would place a unique tool in the hands of pain management specialists across the country. At this time most long term pain relief agents are much higher potency. The availability of an agent that is well tolerated, midpotency and long acting will fill an important need.

Page : 11 to 3 of 3

Subscribe to Updates

By RSS